LEIDEN, Netherlands, April 1, 2022 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces new data from the pivotal Phase II/III
/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/NASDAQ: PHAR) announces positive results from the pivotal Phase.
Benjamin Polson was killed last week in the line of duty while fighting a vacant house fire in north city. Funeral and visitation services begin Wednesday.
An agreed PIP is the regulatory pathway to market authorization for leniolisib as a treatment of activated phosphoinositide 3-kinase delta syndrome in children LEIDEN, Netherlands, Jan.